Delivery Order SPE2DR25D2217-SPE2DR26FC7HC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $37,329.50 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on September 4, 2025, with completion targeted for September 5, 2025. This non-competed, firm fixed-price delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a $17,560.28 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). The contract, which is non-set-aside and competitively awarded, is scheduled for completion by January 2, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $13,124.59 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units) on April 24, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 25, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $122,392.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) with an ultimate completion date of September 30, 2025. This non-set-aside contract was competitively awarded on September 29, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $4,546.64 delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count units). This is a firm fixed price, non-set-aside contract with a completion date of May 9, 2025, and performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $13,125.67 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count packages) on January 5, 2026, with completion scheduled for January 6, 2026. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of NURTEC ODT 75 mg tablets (8-count units) with a contract value of $9,535.18. This is a firm fixed-price delivery order with an ultimate completion date of January 6, 2026, and represents a non-competed award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,717.26 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on November 12, 2025, with an ultimate completion date of November 13, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $8,296.38 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packaging). This is a firm fixed-price delivery order with no set-aside designation, awarded on May 16, 2025, with an ultimate completion date of May 19, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,708.58 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8 count) on December 11, 2025, with an ultimate completion date of December 12, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing Indefinite...
- SPE2DR25D2217Indefinite Delivery Contract
- SPE2DR25D2217-SPE2DR26FC7HCDelivery Order
The Defense Logistics Agency awarded a $4,941.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of NURTEC ODT 75 mg tablets (8-count units). The contract, which is a non-set-aside, competitively awarded delivery order, will be fulfilled at the awardee's Conshohocken, Pennsylvania facility, with an ultimate completion date of January 12, 2026. This delivery order operates under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company demonstrates significant capability in fulfilling federal pharmaceutical supply requirements through open competition, with a track record of delivering diverse therapeutic products including specialty medications, brand-name and generic drugs, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for NURTEC ODT—a migraine treatment medication—exemplifies the company's role in supplying essential prescription medications to support Defense Health Agency and other federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 1/8/26 |